Go to Page # Page of 54
loading

TNBC: How Far Are We from a Precision Medicine Approach?

 Yuan Yuan MD PhD
  14th-Feb-2019
Description: Triple-negative breast cancer (TNBC) refers to any breast cancer that doesn't express the genes for ER (estrogen receptor), PR (progesterone receptor) and HER2/neu.
Views: 4383
Domain: Medical
Category: Therapy
Contributing Organization: City of Hope
 ‐ More of their Presentations
Contents:
TNBC: How Far Are We from a Precision
Medicine Approach?
Yuan Yuan, MD, PhD
Associate Professor
Department of Medical Oncology & Therapeutics Research
City of Hope Multidisciplinary Approaches to Cancer Symposium 2018

DISCLOSURE

• Grant/Research Support from Puma, Eisai,
Novartis, Merck, Pfizer, Genentech
• Consultant for Puma
• Speakers Bureau for Eisai

Outline
• Overview ... See more

Recent Presentations

...
17 September, 2019

IMAP Medical Devices

Here describe the IMAPs experience in healthcare buy-side advisory and deep knowledge of the industry were key factors in successfully closing the transaction.

IMAP
16 September, 2019
PFCD
15 September, 2019